Found 1485 matching trials
Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14 PHASE3 Summary
In patients with prostate cancer (PC) who have only biochemically ...
Show More Location
Copenhagen University hospital, Rigshospitalet
Learn More & Join Trial
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer PHASE2 Researchers conducting this study hope to learn about the safety and effect...
Show More Location
University of Chicago Comprehensive Cancer Center
Learn More & Join Trial
Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer PHASE2 The primary objective of this study is to determine whether zoledronic acid...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 Diabetes PHASE3 Men with metabolic syndrome often have lower than normal testosterone level...
Show More Location
Karolinska University Hospital
Learn More & Join Trial
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC PHASE3 The purpose of this study is to determine if the addition of apalutamide to...
Show More Status
Active Not Recruiting
Location
Multiple Locations
Learn More & Join Trial
Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer PHASE1 This partially randomized phase Ib/II trial studies the side effects and be...
Show More Location
University of Alabama, Birmingham
Learn More & Join Trial
Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men PHASE1 This is a prospective, randomized, double-blinded, two-center trial to eval...
Show More Location
LA Biomedical Research Institute
Learn More & Join Trial
Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET PHASE2 This is a phase 2, open-label, randomized study of adjuvant treatment in su...
Show More Location
Dept of Surgical Sciences - Urology, Molinette Hospital, University of Torino
Learn More & Join Trial
A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer PHASE1 This is an open label, non-randomized, Phase I, dose escalation/dose expans...
Show More Location
Johns Hopkins University School of Medicine
Learn More & Join Trial
Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study N/A Although compelling evidence from laboratory studies suggests that androgen...
Show More Location
University of California, San Francisco
Learn More & Join Trial